Literature DB >> 33586761

Construction, characterization and crystal structure of a fluorescent single-chain Fv chimera.

Nileena Velappan1,2, Devin Close3,2, Li-Wei Hung1,2, Leslie Naranjo1,4, Colin Hemez5, Natasha DeVore6, Donna K McCullough2, Antonietta M Lillo1, Geoffrey S Waldo1, Andrew R M Bradbury4.   

Abstract

In vitro display technologies based on phage and yeast have a successful history of selecting single-chain variable fragment (scFv) antibodies against various targets. However, single-chain antibodies are often unstable and poorly expressed in Escherichia coli. Here, we explore the feasibility of converting scFv antibodies to an intrinsically fluorescent format by inserting the monomeric, stable fluorescent protein named thermal green, between the light- and heavy-chain variable regions. Our results show that the scTGP format maintains the affinity and specificity of the antibodies, improves expression levels, allows one-step fluorescent assay for detection of binding and is a suitable reagent for epitope binning. We also report the crystal structure of an scTGP construct that recognizes phosphorylated tyrosine on FcεR1 receptor of the allergy pathway.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  crystal structure; epitope binning; improved expression and functionality; intrinsically fluorescent scFv antibodies; soluble scFv antibodies

Year:  2021        PMID: 33586761      PMCID: PMC7901706          DOI: 10.1093/protein/gzaa029

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  45 in total

1.  Getting to reproducible antibodies: the rationale for sequenced recombinant characterized reagents.

Authors:  Andrew R M Bradbury; Andreas Plückthun
Journal:  Protein Eng Des Sel       Date:  2015-10       Impact factor: 1.650

2.  High level production of soluble single chain antibodies in small-scale Escherichia coli cultures.

Authors:  S M Kipriyanov; G Moldenhauer; M Little
Journal:  J Immunol Methods       Date:  1997-01-15       Impact factor: 2.303

3.  Specific detection of his-tagged proteins with recombinant anti-His tag scFv-phosphatase or scFv-phage fusions.

Authors:  P Lindner; K Bauer; A Krebber; L Nieba; E Kremmer; C Krebber; A Honegger; B Klinger; R Mocikat; A Plückthun
Journal:  Biotechniques       Date:  1997-01       Impact factor: 1.993

Review 4.  High avidity scFv multimers; diabodies and triabodies.

Authors:  P J Hudson; A A Kortt
Journal:  J Immunol Methods       Date:  1999-12-10       Impact factor: 2.303

5.  Development of Anti-Yersinia pestis Human Antibodies with Features Required for Diagnostic and Therapeutic Applications.

Authors:  Antonietta M Lillo; Nileena Velappan; Julia M Kelliher; Austin J Watts; Samuel P Merriman; Grace Vuyisich; Laura M Lilley; Kent E Coombs; Tara Mastren; Munehiro Teshima; Benjamin W Stein; Gregory L Wagner; Srinivas Iyer; Andrew R M Bradbury; Jennifer Foster Harris; Armand E Dichosa; Stosh A Kozimor
Journal:  Immunotargets Ther       Date:  2020-11-27

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  Secretion of a single-gene-encoded immunoglobulin from myeloma cells.

Authors:  L Shu; C F Qi; J Schlom; S V Kashmiri
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

8.  Construction of solid matrix-antibody-antigen complexes containing simian immunodeficiency virus p27 using tag-specific monoclonal antibody and tag-linked antigen.

Authors:  T Hanke; P Szawlowski; R E Randall
Journal:  J Gen Virol       Date:  1992-03       Impact factor: 3.891

9.  Beyond natural antibodies: the power of in vitro display technologies.

Authors:  Andrew R M Bradbury; Sachdev Sidhu; Stefan Dübel; John McCafferty
Journal:  Nat Biotechnol       Date:  2011-03       Impact factor: 54.908

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.